SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-006236
Filing Date
2018-08-02
Accepted
2018-08-02 16:23:26
Documents
58
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q crvs-20180630x10q.htm 10-Q 1588348
2 EX-10.2 crvs-20180630ex102fdcaa6.htm EX-10.2 84160
3 EX-31.1 crvs-20180630ex3114044ba.htm EX-31.1 13411
4 EX-31.2 crvs-20180630ex31258bc2f.htm EX-31.2 13359
5 EX-32.1 crvs-20180630ex321927990.htm EX-32.1 13630
6 GRAPHIC crvs20180630ex102fdcaa6001.jpg GRAPHIC 41308
7 GRAPHIC crvs20180630ex102fdcaa6002.jpg GRAPHIC 66505
  Complete submission text file 0001558370-18-006236.txt   5253377

Data Files

Seq Description Document Type Size
8 EX-101.INS crvs-20180630.xml EX-101.INS 1033273
9 EX-101.SCH crvs-20180630.xsd EX-101.SCH 33379
10 EX-101.CAL crvs-20180630_cal.xml EX-101.CAL 45355
11 EX-101.DEF crvs-20180630_def.xml EX-101.DEF 86588
12 EX-101.LAB crvs-20180630_lab.xml EX-101.LAB 305037
13 EX-101.PRE crvs-20180630_pre.xml EX-101.PRE 206509
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37719 | Film No.: 18988691
SIC: 2834 Pharmaceutical Preparations